Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partnership with SADA, an...
-
MIAMI, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Nabla and Opus EHR, two trailblazing names in the healthcare technology sector, have united in a groundbreaking partnership that promises to redefine...
-
SAN FRANCISCO, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to...
-
SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems,...
-
MIAMI, May 11, 2023 (GLOBE NEWSWIRE) -- Opus EHR, a leading innovative behavioral health solutions provider, is thrilled to announce its partnership with Aroris, a contract negotiation company, to...
-
SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leading provider of ambient medical documentation and data solutions delivered remotely to healthcare systems, physician...
-
FORT WORTH, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Today, Snap Health, a healthcare technology company specializing in connecting clinicians with home health agencies through a revolutionary...
-
TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Smile CDR Inc., a leading health data and integration platform, today welcomed Shane McNamee, MD, as its new chief medical information officer (CMIO). Dr....
-
Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its...
-
SARATOGA, Calif., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Today Silicon Valley-based CapsoVision, Inc. announced CE Mark approval for their CapsoCam Plus® System in patients ages 2 and above*. It is the...